Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05657314 · ClinicalTrials.gov registry record · NA

Effects of Pea Proteins on Muscle Damage and Recovery

A NA study, sponsored by The Center for Applied Health Sciences.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05657314 is a NA study that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05657314, a NA study, has completed, sponsored by The Center for Applied Health Sciences.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This study is a double-blind, randomized, placebo-controlled, crossover clinical trial of N=40 recreationally active men to be recruited a single investigational center in Ohio (i.e., The Center for Applied Health Sciences). Subjects will take a daily protein supplement (e.g., 15 g of pea protein or 15 g of pea protein + probiotic blend) for 4 weeks, have a 1-week washout period (i.e. meaning they will not take either supplement), and then take the alternate protein supplement for an additional 4 weeks. Outcome variables include plasma amino acids, muscle damage, muscle recovery, and GI tolerance.

Interventions

  • DIETARY_SUPPLEMENT Active Comparator

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-01-06
Est. Completion 2022-10-06
Phase NA

What the Registry Record Tells You About NCT05657314

The ClinicalTrials.gov registry entry for NCT05657314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Applied Health Sciences, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Active Comparator is the first listed.

NCT05657314 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05657314 about?

NCT05657314 is a clinical study titled "Effects of Pea Proteins on Muscle Damage and Recovery". This study is a double-blind, randomized, placebo-controlled, crossover clinical trial of N=40 recreationally active men to be recruited a single investigational center in Ohio (i.e., The Center for Applied Health Sciences). Subjects will take a daily protein supplement (e.g., 15 g of pea protein o...

What is the current status of trial NCT05657314?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-01-06. Estimated completion is 2022-10-06.

What interventions are being tested in trial NCT05657314?

The interventions under investigation include: Active Comparator (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05657314?

This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.